Cue Biopharma, Inc. (CUE)
NCM · Common · CUSIP 22978P106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CUE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
22978P106
Market Cap
Small Cap
IPO
1/2/2018 · $7.50/share
Business: Cue Biopharma, Inc. is an innovative immunotherapy company dedicated to developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders.

Company Contact

CEO
Lucinda Warren
CFO
Kerri-Ann Millar
Headquarters
40 Guest Street, Boston, MA 02135
Phone
617-949-2680
Investor Relations
Kerri-Ann Millar · 617-949-2602 · IR@cuebio.com
SEC EDGAR Filings
View filings »